Assessment of hepatic function is particularly important because transplantation may be necessary due to the progression of hepatic fibrosis or repeated bouts of inflammation.
Quantitative assessment of hepatic function reserve before the occurrence of liver cirrhosis has been paid much attention in clinical practice in recent years.
Baseline safety and toxicity evaluations included history and physical examination, 12-lead ECG, and complete blood count with differential, metabolic, hepatic, and renal function assessments.
Because the accumulation of GSA in normal hepatocytes for an injection dose is relatively high, the frequent appearance of a streak artifact is an intractable problem in the quantitative assessment of the hepatic function by the use of a filtered back projection (FBP) algorithm when image reconstruction (FBP reconstruction) is used.
Assessments for haematology, hepatic function and toxicity were conducted at baseline, 3-weekly during induction chemotherapy (weekly for complete blood count haemoglobin, lymphocytes (with white blood cell differentials) and platelets), and weekly throughout local treatment (every 2 days in case of grade 4 or febrile neutropenia).
The completeness of individual tests at each assessment time is generally high, except for hepatic function tests, which were often overlooked, especially at later assessments (Table 2).
Laboratory assessments (hematology, renal function, hepatic function, electrolytes, and urinalysis), vital sign determinations (blood pressure, pulse rate, temperature, and respiration rate), and body weight measurements were performed at baseline, day 3, and day 10 ± 2 (Cohorts 1 and 2), or at day 7 and day 15 ± 2 (Cohort 3), and upon early withdrawal, if applicable.
Patients attended for baseline assessment of disease severity and blood was obtained for standard laboratory assessments of full blood count, electrolytes, renal and hepatic function hematology and biochemistry.
Alterations in Hepatic Function -- Module 31.
DSePA inhibited radiation-induced hepatic lipid peroxidation, protein carbonylation, loss of hepatic function, and damage to the hepatic architecture.
Thus, alterations in hepatic function contribute to the increase in systemic BAs after RYGB.
